January 22nd, 2025
Out of the lab and into patients’ hands
Harvard Move Lab makes a wearable robotic device for stroke survivors.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Bioengineering
October 2nd, 2024
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
Attivare Therapeutics, a Harvard startup out of the Wyss Institute, has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS), Dana-Farber Cancer Institute, and Massachusetts General Hospital. This technology creates an in vivo training ground for the immune system to fight cancer more effectively and prevent infection.
August 7th, 2024
3D-printed blood vessels bring artificial organs closer to reality
New printing method creates branching vessels in heart tissue that replicate the structure of human vasculature in vitro.
April 9th, 2024
Wyss Institute’s AminoX project receives funding from Northpond Labs to accelerate innovation in protein-based therapeutics
Northpond-funded Laboratory for Bioengineering Research and Innovation makes its fourth investment into the future of biotech.
January 29th, 2024
A long-lasting neural probe
Researchers develop implantable device that can record a collection of individual neurons over months.
